We are live on ! Find out more
VIMU

Veritas Investment Management (UK) Portfolio holdings

AUM $648M
1-Year Est. Return 36.52%
This Fund
S&P 500
This Quarter Est. Return
+1.63%
1 Year Est. Return
+36.52%
3 Year Est. Return
+151.05%
5 Year Est. Return
+218.12%
10 Year Est. Return
AUM
$243M
AUM Growth
+$36.4M
Cap. Flow
+$29.7M
Cap. Flow %
12.21%
Top 10 Hldgs %
69.63%
Holding
59
New
8
Increased
12
Reduced
13
Closed
12

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$15.8M
2
FNV icon
Franco-Nevada
FNV
+$5.76M
3
WAT icon
Waters Corp
WAT
+$3.62M
4
UNH icon
UnitedHealth
UNH
+$3.28M
5
FISV
Fiserv Inc
FISV
+$1.33M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$12.8M
2
CTSH icon
Cognizant
CTSH
+$3.2M
3
BP icon
BP
BP
+$914K
4
MSFT icon
Microsoft
MSFT
+$723K
5
CSCO icon
Cisco
CSCO
+$317K

Sector Composition

Rank Sector Weight
1 Healthcare 22.82%
2 Technology 20.32%
3 Financials 16.85%
4 Communication Services 15.17%
5 Energy 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
26
General Mills
GIS
$19.7B
$428K 0.18%
6,930
MRK icon
27
Merck
MRK
$324B
$416K 0.17%
7,409
KO icon
28
Coca-Cola
KO
$374B
$366K 0.15%
8,830
PEP icon
29
PepsiCo
PEP
$189B
$356K 0.15%
3,400
JNJ icon
30
Johnson & Johnson
JNJ
$631B
$330K 0.14%
2,860
AAPL icon
31
Apple
AAPL
$4.48T
$283K 0.12%
9,788
+1,388
+17% +$39.4K
JPM icon
32
JPMorgan Chase
JPM
$961B
$261K 0.11%
3,030
WFC icon
33
Wells Fargo
WFC
$267B
$214K 0.09%
3,885
-810
-17% -$40.7K
IBM icon
34
IBM
IBM
$223B
$173K 0.07%
1,093
INTC icon
35
Intel
INTC
$489B
$149K 0.06%
4,100
-8,000
-66% -$286K
PFE icon
36
Pfizer
PFE
$155B
$133K 0.05%
4,321
DD
37
DELISTED
Du Pont De Nemours E I
DD
$103K 0.04%
1,400
-1,100
-44% -$78.1K
LH icon
38
Labcorp
LH
$26.1B
$98K 0.04%
885
+24
+3% +$2.67K
ZTS icon
39
Zoetis
ZTS
$31.2B
$89K 0.04%
+1,670
New +$84.9K
FLR icon
40
Fluor
FLR
$7.06B
$66K 0.03%
1,250
-1,250
-50% -$64.9K
CB icon
41
Chubb
CB
$135B
$14K 0.01%
108
VZ icon
42
Verizon
VZ
$196B
$8K ﹤0.01%
145
ANF icon
43
Abercrombie & Fitch
ANF
$5.18B
-110
Closed -$2K
CSCO icon
44
Cisco
CSCO
$477B
-10,000
Closed -$317K
DLB icon
45
Dolby
DLB
$5.76B
-5,000
Closed -$271K
GLW icon
46
Corning
GLW
$138B
-7,500
Closed -$177K
JEF icon
47
Jefferies Financial Group
JEF
$13B
-11,171
Closed -$190K
L icon
48
Loews
L
$23.3B
-5,000
Closed -$206K
ORCL icon
49
Oracle
ORCL
$428B
-325,312
Closed -$12.8M
TPR icon
50
Tapestry
TPR
$32.7B
-6,000
Closed -$219K

Similar funds

Veritas Investment Management (UK)'s Q4 2016 Portfolio in Review

As of Q4 2016, Veritas Investment Management (UK) held 59 positions worth $243M, up 18% from $207M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Veritas Investment Management (UK) deployed $29.7M of net new capital in Q4 2016, opening 8 new positions and adding to 12 existing holdings. Its largest new stake was Thermo Fisher Scientific: 107,495 shares worth $15.2M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Cognizant, an estimated $3.2M trimmed.

  • Veritas Investment Management (UK)'s largest Q4 2016 buy was Thermo Fisher Scientific: 107,495 shares worth $15.2M.
  • Veritas Investment Management (UK) added most to Franco-Nevada in Q4 2016, an estimated $5.76M increase.
  • Veritas Investment Management (UK)'s biggest Q4 2016 reduction was Cognizant, cutting an estimated $3.2M.
  • Veritas Investment Management (UK) fully exited Oracle in Q4 2016, selling an estimated $12.8M.
  • Veritas Investment Management (UK)'s ten largest holdings make up 70% of its $243M portfolio in Q4 2016.
  • Veritas Investment Management (UK) opened 8 new positions and closed 12 in Q4 2016.
  • Veritas Investment Management (UK)'s portfolio value rose 18% quarter-over-quarter to $243M.

Based on Veritas Investment Management (UK)'s 13F filing for Q4 2016, filed 31 Jan 2017.